Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines

Metablic Syndrome

The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer

E. M. Guinan; E. M. Connolly; L. A. Healy; P. A. Carroll; M. J. Kennedy; J. Hussey The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer Cancer Nursing
Insulin resistance & diabetes Metablic Syndrome

Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent

J. A. Elliott; N. E. Donlon; P. Beddy; C. L. Donohoe; S. L. Doyle; S. King; N. Ravi; J. V. Reynolds Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent Dis Esophagus
Metablic Syndrome

IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity

S. L. Doyle; C. L. Donohoe; S. P. Finn; J. M. Howard; F. E. Lithander; J. V. Reynolds; G. P. Pidgeon; J. Lysaght IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity Am J Gastroenterol
Metablic Syndrome

The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer

E. M. Guinan; E. M. Connolly; L. A. Healy; P. A. Carroll; M. J. Kennedy; J. Hussey The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer Cancer Nursing
Insulin resistance & diabetes Metablic Syndrome

Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent

J. A. Elliott; N. E. Donlon; P. Beddy; C. L. Donohoe; S. L. Doyle; S. King; N. Ravi; J. V. Reynolds Visceral obesity with and without metabolic syndrome: incidence and clinical impact in esophageal adenocarcinoma treated with curative intent Dis Esophagus
Metablic Syndrome

IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity

S. L. Doyle; C. L. Donohoe; S. P. Finn; J. M. Howard; F. E. Lithander; J. V. Reynolds; G. P. Pidgeon; J. Lysaght IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity Am J Gastroenterol
Metablic Syndrome

Search for:

Recent Posts

ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update
ECO2023 Teaching Workshops – Registration Open!
“Addressing Obesity Together” – Press Release

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines

Privacy Policy
Site Map

©2023 ASOI